Research Results from Affiliated Hospital of Nanjing University Medical School Update Knowledge of Cholangiocarcinoma (Targeting CD44 variant 5 with an antibody-drug conjugate is an effective therapeutic strategy for intrahepatic...).

Předmět:	ANTIBODY-drug conjugates UNIVERSITY hospitals MEDICAL schools CHOLANGIOCARCINOMA CD44 antigen
Zdroj:	Cancer Weekly; 6/6/2023, p785-785, 1p
Abstrakt:	Keywords: Antibodies; Blood Proteins; Cancer; Cholangiocarcinoma; Drug Conjugates; Drug Development; Drugs and Therapies; Health and Medicine; Immunoglobulins; Immunology; Oncology; Proteins; Therapeutics; Therapy EN Antibodies Blood Proteins Cancer Cholangiocarcinoma Drug Conjugates Drug Development Drugs and Therapies Health and Medicine Immunoglobulins Immunology Oncology Proteins Therapeutics Therapy 785 785 1 06/05/23 20230606 NES 230606 2023 JUN 6 (NewsRx) -- By a News Reporter-Staff News Editor at Cancer Weekly -- A new study on cholangiocarcinoma is now available. Antibodies, Blood Proteins, Cancer, Cholangiocarcinoma, Drug Conjugates, Drug Development, Drugs and Therapies, Health and Medicine, Immunoglobulins, Immunology, Oncology, Proteins, Therapeutics, Therapy. [Extracted from the article]
Databáze:	Complementary Index
Externí odkaz:	Zobrazit plný text záznamu